Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.31
+0.22 (1.15%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Sabra Health Care REIT stock has a consensus rating of "Buy" and an average price target of $22.15. The average 1-year stock price forecast is 14.71% higher than the current stock price, while the lowest is $19 (-1.61%) and the highest is $25 (+29.47%).
Price Target: $22.15 (+14.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 7 | 7 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 13 | 13 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Seth Bergey Citi No rating | Citi | Hold Downgrades $24 → $19 | Hold | Downgrades | $24 → $19 | -1.61% | Jun 22, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $22 → $19 | Hold | Maintains | $22 → $19 | -1.61% | Jun 18, 2026 |
| Raymond James | Raymond James | Sell Initiates $19 | Sell | Initiates | $19 | -3.00% | Jun 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $25 | Buy | Maintains | $25 | +29.47% | Jun 10, 2026 |
| UBS | UBS | Hold Reiterates $21 → $22 | Hold | Reiterates | $21 → $22 | +13.93% | May 13, 2026 |
Financial Forecast
Revenue This Year
888.69M
from 775.76M
Increased by 14.56%
Revenue Next Year
983.71M
from 888.69M
Increased by 10.69%
EPS This Year
0.67
EPS Next Year
0.74
from 0.67
Increased by 10.94%
EPS based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 944.0M | ||
| Avg | 888.7M | ||
| Low | 800.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.7% | ||
| Avg | 14.6% | ||
| Low | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.67 | ||
| Avg | 0.67 | ||
| Low | 0.67 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.1% | ||
| Avg | 11.1% | ||
| Low | 11.1% |